Surgery now versus radiation then delayed surgery for DCIS
Part of Cancer, Skin clinical trials.
This trial compares two approaches for ductal carcinoma in situ (DCIS): having surgery first versus getting radiation first and then having surgery later. It aims to see which plan controls DCIS better while affecting treatment timing and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your biopsy shows DCIS only (not invasive cancer) on core needle biopsy
- The breast abnormality on imaging is 4 cm or less, and you don’t have a palpable lump
- You had a needle biopsy within 16 weeks before randomization, and a marker was placed for surgery/radiation planning
- Your planned surgery is usually lumpectomy (breast-conserving). Mastectomy may be allowed only in specific situations after randomization
- A radiation specialist believes partial breast radiation is feasible (about 30% or less of the breast volume)
- You can’t have had prior radiation to the same breast, and you can’t be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information from people with breast ductal carcinoma in situ (DCIS) to see how a specific lab test (DCISionRT) may help predict who benefits from radiation and/or certain medications. Your results and clinical details are gathered during routine care, not necessarily to change treatment right away.
This trial studies giving radiation during surgery for women with a certain early breast condition called ductal carcinoma in situ (DCIS). It may help lower the chance that the DCIS comes back, especially when combined with breast-conserving surgery.
This trial compares skipping radiation therapy after breast-conserving surgery for low- or intermediate-risk ductal carcinoma in situ (DCIS) – a very early, non-invasive breast cancer. It aims to see if omitting radiation is as effective as standard treatment while reducing side effects.
This study uses a special test (DCISionRT) on tissue from your breast surgery to help doctors decide if radiation therapy is right for you after lumpectomy for DCIS (a non-invasive form of breast cancer). The goal is to personalize treatment based on your individual cancer characteristics.
This trial tests giving radiation to the tumor area before surgery for women with early-stage, hormone-sensitive breast cancer. The idea is to see if giving radiation first can help protect healthy tissue while still being effective.
This trial tests a single, targeted radiation treatment given during or after lumpectomy for early-stage breast cancer. It aims to make treatment more convenient while keeping the same safety and effectiveness as longer radiation courses.
Hear when a new Ductal Breast Carcinoma in Situ trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.